Open Access
LogoLogo
About JournalArchiveSearchFor AuthorsFor ReviewersHelpOnline-Submission
Archive
Vol.48, No.1, 2014
Current Issue
Archive (2009~
Archive-the Korean Journal of Pathology(1967~2008)
Archive-the Korean Journal of Cytopathology(1990~2008)
Most Read Articles
  Vol.47, No.2:100-106, April 2013
Review & perspective articles
Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group

Hyo Sup Shim* · Jin-Haeng Chung1* Lucia Kim2 · Sunhee Chang3 Wan-Seop Kim4 · Geon Kook Lee5 Soon-Hee Jung6 · Se Jin Jang7

Department of Pathology, Yonsei University College of Medicine, Seoul; 1Department of Pathology, Seoul National University Bundang Hospital, Seongnam; 2Department of Pathology, Inha University School of Medicine, Incheon; 3Department of Pathology, Ilsan Paik Hospital, Inje University College of Medicine, Goyang; 4Departments of Pathology, Konkuk University School of Medicine, Seoul; 5Department of Pathology, National Cancer Center, Goyang; 6Department of Pathology, Yonsei University Wonju College of Medicine, Wonju; 7Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Mutations of the epidermal growth factor receptor (EGFR) are the strongest predictive factor for response to EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib. EGFR TKIs are approved in Korea as a first-line treatment for lung cancer patients with mutated EGFR. Rapid and accurate EGFR mutation testing is essential for patient selection and establishing targeted therapies with EGFR TKIs. Thus, a standard set of guideline recommendations for EGFR mutation testing suitable for the Korean medical community is necessary. In this article, we propose a set of guideline recommendations for EGFR mutation testing that was discussed and approved by the Cardiopulmonary Pathology Study Group of the Korean Society of Pathologists.
Key Words : Mutation; Receptor, epidermal growth factor; Guideline

Copyright(c) 2008 By the Korean Society of Pathologists & the Korean Society for Cytopathology
Room 1209 Gwanghwamun Officia, 163 Sinmunno 1-ga, Jongno-gu, Seoul 110-999, Korea
Tel: +82-2-795-3803, 3094, Fax: +82-2-790-6635, E-mail: kjpath@kams.or.kr.
#406 Lilla Swami Bldg, 391-18, Yangjae-dong, Seocho-gu, Seoul 137-130, Korea
Tel: +82-2-593-6943 Fax: +82-2-593-6944, E-mail: cytopathology@hanmail.net